Overview
-

Kitazato Corporation

Kitazato Corporation is a Japanese medical device and reagent manufacturer specializing in assisted reproductive technology (ART), providing comprehensive products for in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) procedures. The company's core product portfolio includes cryopreservation devices (notably the 'Cryotop' vitrification carrier), embryo transfer catheters, oocyte retrieval needles, culture media, and microtools, all manufactured domestically at its Shizuoka facility under strict quality standards. Products are sold in approximately 110 countries and regions through a network of approximately 80 distributors, with strategic focus on high-growth markets including the United States and China.

Market Cap
¥54.7B
US$349M
EV
¥42.2B
US$269M
Stock¥1,367▼-0.94%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
6.6
x
LTM EV/EBIT
6.8
x
LTM PER
13.2
x
LTM PBR
2.8
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-22.0%pt
1001
Oct 24, 25 – Oct 23, 26StockTOPIX
1Aug 3, 26Q1 FY2027/03 earnings announced
MC → EV Bridge
54.7BUS$349MMarket Cap0.00BUS$0.00M+ Debt12.5BUS$79.8M− Cash0.00BUS$0.00M− Inv. Sec.42.2BUS$269MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
9.35US$59.6M'23/310.1US$64.3M'24/310.3US$65.7M'25/310.9US$69.8M'26/3
Net Income 5Y (¥B)
3.37US$21.5M'23/33.97US$25.3M'24/33.79US$24.2M'25/33.90US$24.8M'26/3
Capital Structure
100%
EquityDebt
Liquidity vs Debt 5Y (¥B)
CashInv. Sec.Debt
'23/3'24/3'25/313.4US$85.5M'26/3
Shareholders
Top 10 hold 81.6%
1
Kitazato Shoji Co., Ltd.
55.75%
2
The Master Trust Bank of Japan, Ltd. (Trust Account)
6.87%
3
Custody Bank of Japan, Ltd. (Trust Account)
5.11%
4
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)
3.17%
5
Taiju INOUE (Representative Director, President of the Company)
3.00%
6
GOVERNMENT OF NORWAY (Standing Proxy: Citibank, N.A., Tokyo Branch)
2.88%
7
HSBC BANK PLC A/C M AND G(ACS) VALUE PARTNERS CHINA EQUITY FUND (Standing Proxy: The Hongkong and Shanghai Banking Corporation Limited, Tokyo Branch)
1.40%
8
BBH FOR BBHTSIL NEUBERGER BERMAN INVESTMENT FUNDS PLC-NEUBERGER BERMAN JAPAN EQUITY ENGAGEMENT FUND (Standing Proxy: MUFG Bank, Ltd.)
1.28%
9
MSIP CLIENT SECURITIES (Standing Proxy: Morgan Stanley MUFG Securities Co., Ltd.)
1.12%
10
STATE STREET BANK AND TRUST COMPANY 505025 (Standing Proxy: Mizuho Bank, Ltd.)
1.01%
Management
12 officers
Taiju INOUE
Representative Director, President
Born Nov 1970 Apr 1996 Joined Kitazato Supply Co., Ltd. Apr 1998 Director, Kitazato Bio Research Institute Apr 2005 Representative Director, Kitazato BioPharma Co., Ltd. Oct 2005 Director, Kitazato Supply Co., Ltd. Feb 2006 Representative Director, Kitazato Supply Co., Ltd. Apr 2007 Representative Director, Kitazato Medical Co., Ltd. (now the Company) (current) Nov 2008 Representative Director, Kitazato Corporation Co., Ltd. Dec 2008 Representative Director, Kitazato Science Co., Ltd. (now Kitazato Bioscience Co., Ltd.) (current) Jun 2011 Representative Director, PGD-KS Co., Ltd. (now Kitazato Healthcare Co., Ltd.) (current) Feb 2016 Representative Director, Kitazato Clinical Laboratory Center Co., Ltd. (current) Sep 2016 Representative Director, Kitazato Shoji Co., Ltd. (current) Mar 2022 Representative Director, Kitazato Cryobank Co., Ltd. (current) Jun 2023 Representative Director, Kitazato America, Inc. (current)
1970-11-22
Kyoko IZUMI
Managing Director, General Manager, Quality Assurance Department
Aug 1998 Joined Big Shot Trading Co., Ltd. Aug 2005 Joined Oshman's Japan Co., Ltd. Dec 2007 Joined Kinari Co., Ltd. Aug 2009 Joined Tanaka Kosan Co., Ltd. Aug 2010 Joined Shizuoka Career Station Co., Ltd. May 2011 Joined Kitazato BioPharma Co., Ltd. Dec 2017 Joined PC System Co., Ltd. Mar 2021 Joined the Company; General Manager, Quality Assurance Department Jun 2022 Director, General Manager, Quality Assurance Department Aug 2023 Managing Director, General Manager, Quality Assurance Department Nov 2023 Managing Director, in charge of Quality Assurance; General Manager, Quality Assurance Department (current)
1977-10-16
Maki OGAWA
Director, General Manager, Marketing Department and Sales Department
Apr 2002 Joined Hoshibi Gakuen (school corporation) Jun 2006 Joined Fuji Co., Ltd. Apr 2007 Joined Motono Law Office Feb 2008 Joined Treat Co., Ltd. Feb 2010 Joined the Company Apr 2021 General Manager, Marketing Department Jun 2022 Director, General Manager, Marketing Department Jun 2023 Director, Kitazato America, Inc. (current) Sep 2024 Director, General Manager, Marketing Department and Sales Department (current)
1979-12-16
Kazumi SHIBATA
Director, General Manager, Manufacturing Department
Apr 1998 Joined Kowa Co., Ltd. Apr 2007 Joined Fuji Sangyo Co., Ltd. Oct 2009 Joined Polyplastics Co., Ltd. Aug 2011 Joined Shizuoka Career Station Co., Ltd. Aug 2013 Joined the Company Mar 2021 General Manager, Manufacturing Department Jun 2022 Director, General Manager, Manufacturing Department Nov 2023 Director, in charge of Manufacturing; General Manager, Manufacturing Department (current)
1977-11-27
Yushō SUZUKI
Director, General Manager, Corporate Planning Department
Apr 1997 Joined HKS Co., Ltd. Aug 2004 Auditor, HKS Technical Factory Co., Ltd. Aug 2008 Auditor, Nissei Kogyo Co., Ltd. Sep 2011 Joined Suruga Seisan Platform Co., Ltd. Apr 2016 General Manager, OST Enterprise Management Department, Suruga Seisan Platform Co., Ltd. Apr 2018 General Manager, OST Enterprise Business Management Office, Suruga Seisan Platform Co., Ltd. Dec 2018 Supervisor, Suruga Seiki Technology (Shanghai) Co., Ltd. Jan 2024 Joined the Company Feb 2024 Director, the Company Apr 2024 Director, General Manager, Corporate Planning Department Oct 2024 Director, in charge of Administration; General Manager, Corporate Planning Department (current)
1974-11-27
Makoto SHINTANI
Director
Apr 1981 Joined Nippon Mining Co., Ltd. (now ENEOS Corporation) Oct 2002 Joined Sumitomo Pharma Co., Ltd. Oct 2004 Joined NanoCarrier Co., Ltd. Jan 2007 Joined Japan Energy Corporation (now ENEOS Corporation) Jan 2007 Director, IS Japan Co., Ltd. Aug 2007 Board Director, CEO, Irvine Scientific Sales Company Inc. Aug 2011 Joined Covidien Japan; Head of R&D Nov 2013 Director, Head of Global Business R&D Division, Beckman Coulter Japan Apr 2015 Executive Officer, Management Strategy Division, Nikon Corporation Aug 2016 Executive Officer, Medical Business Promotion Division (now Healthcare Business Division), Nikon Corporation Jun 2017 Executive Officer, Healthcare Business Division, Nikon Corporation May 2018 Board Director, Berkeley Lights Inc. Apr 2019 Senior Fellow, Nikon Corporation Aug 2022 Board Director, Nortis Inc. Aug 2022 Outside Director, the Company (current)
1957-01-21
Ignacio BAMEJO
Director
Jul 1990 Internship, Banco Santander Oct 1990 Joined El Corte Ingles Jul 1992 Internship, Procter & Gamble Sep 1993 Joined C&A Modas Jan 1995 Joined Antena 3 Television Oct 1999 Joined Onda Cero Radio Nov 2000 Joined Admira; Purchasing Manager Sep 2003 Joined I+D; Manager Jun 2004 Joined Equipo IVI, S.L.; Purchasing Manager and Logistics Manager Mar 2008 Managing Director, Biomedical Supply, S.L. Jun 2020 Outside Director, the Company (current) Jan 2023 Chief Executive Officer, Biomedical Supply, S.L. (current) Feb 2023 Chief Executive Officer, Biomedical Supply US, Inc. (current) Jan 2025 Chief Executive Officer, Biomedical Supply UK, Ltd. (current) Apr 2026 Officer, Endorse Equipamentos Medicos S.A. (current)
1970-04-03
Shigenori YAMAGUCHI
Director
Apr 1981 Joined Shizuoka Prefectural Police Headquarters Jan 1983 Joined Shizuoka Prefectural Government Oct 2005 Senior Official, Planning Department, Ito City Apr 2006 Director, Ito City Apr 2015 Director General, Health and Welfare Department, Shizuoka Prefectural Government Apr 2018 Vice President and Director of General Affairs, Shizuoka Prefectural Hospital Organization (incorporated administrative agency) (current) Apr 2018 Advisor, Shizuoka Prefectural Government (current) Nov 2019 Secretary General, Hospital Council of Incorporated Administrative Agencies Apr 2021 Director, Fujinokuni Social Health and Medical Alliance (current) Feb 2024 Outside Director, the Company (current)
1958-02-24
Akio SATO
Director
Apr 1997 Registered as Attorney-at-Law (Daini Tokyo Bar Association) Mar 2003 Opened Sato Sogo Law Office (current) Mar 2008 Outside Corporate Auditor, POLA ORBIS HOLDINGS INC. (current) Apr 2012 Part-time Lecturer, Keio Business School (current) Jun 2016 Outside Director, Aozora Bank, Ltd. (now GMO Aozora Net Bank, Ltd.) (current) Jul 2017 Outside Director, U-NEXT Co., Ltd. (now U-NEXT HOLDINGS Co., Ltd.) (current) Mar 2025 Outside Director, the Company (current)
1966-02-04
Yasuhiro TSUNAZAWA
Full-time Statutory Auditor
Apr 1989 Joined Printing Machinery Trading Co., Ltd. Dec 2000 Joined Kitazato Supply Co., Ltd. Apr 2005 Joined Kitazato BioPharma Co., Ltd. Apr 2005 Director, Kitazato BioPharma Co., Ltd. Feb 2017 Director, the Company Jun 2022 Statutory Auditor, the Company (current)
1966-12-03
Shinsuke KATAOKA
Outside Statutory Auditor
Apr 1999 Joined Chiba Bank Sep 2003 Joined Daiwa Tax Corporation Sep 2006 Joined Taiyo Grant Thornton Tax Corporation Feb 2020 Established Shinsuke Kataoka Tax Accountant Office Aug 2020 Joined Chiel Co., Ltd. Jun 2023 Director, Audit and Supervisory Committee Member, Chiel Co., Ltd. (current) Jun 2023 Outside Statutory Auditor, the Company (current)
1975-07-27
Tomoko SANO
Outside Statutory Auditor
Apr 1999 Legal Apprentice, Supreme Court Legal Training and Research Institute Feb 2002 Joined Nagawa Okamura Law Firm Apr 2009 Auditor, National Museum of Nature and Science Apr 2011 Part-time Lecturer, Tokyo College of Music Jan 2016 Partner, Nagawa Okamura Law Firm (current) Apr 2019 Civil Litigation Instructor, Supreme Court Legal Training and Research Institute Apr 2019 Specially Appointed Professor, Tokyo College of Music (current) Aug 2023 Outside Statutory Auditor, the Company (current)
1963-07-02
Large Shareholding Reports
Neuberger Berman Co., Ltd.
2026-08-17
6.15%→7.44%
Nomura Asset Management Co., Ltd.
2026-06-19
4.77%
Neuberger Berman Japan Ltd.
2026-06-01
5.08%→6.15%
Nomura Asset Management Co., Ltd.
2026-05-11
4.04%→4.68%
Nomura Asset Management Co., Ltd.
2026-01-21
4.04%
Neuberger Berman Japan Ltd.
2025-12-01
5.08%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-08-17
Large Shareholding Report
TDnet
2026-07-31
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-24
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-06-19
Large Shareholding Report
EDINET
2026-06-01
Large Shareholding Report
TDnet
2026-05-29
株主総会招集通知
EDINET
2026-05-11
Large Shareholding Report
TDnet
2026-02-06
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2026-01-21
Large Shareholding Report
EDINET
2025-12-01
Large Shareholding Report
EDINET
2025-11-13
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-30
Annual Securities Report
Period: Apr 2024 – Mar 2025
EDINETAmended
2025-06-16
Amended Securities Registration Statement
EDINETAmended
2025-06-09
Amended Securities Registration Statement
EDINET
2025-05-22
Securities Registration Statement
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →